MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-17-2026
ClearPoint Neuro Total Liabilities 2011-2026 | CLPT
Annual Total Liabilities ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.7 M | 13.8 M | 21.5 M | 18.6 M | 16.8 M | 27.1 M | 7.34 M | 6.35 M | 8.07 M | 8.16 M | 12.1 M | 13.5 M | 14.7 M | 11.3 M | 24.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.7 M | 6.35 M | 18.3 M |
Quarterly Total Liabilities ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.5 M | 43.1 M | 10.1 M | 13.8 M | 11.2 M | 20.4 M | 19.1 M | 21.5 M | 19.7 M | 20.2 M | 17.7 M | 18.6 M | 17.9 M | 17.4 M | 16 M | 16.8 M | 24.6 M | 24.4 M | 30.3 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 7.34 M | 7.34 M | 7.34 M | 7.34 M | 6.35 M | 6.35 M | 6.35 M | 6.35 M | 8.07 M | 8.07 M | 8.07 M | 8.07 M | 8.16 M | 8.16 M | 8.16 M | 8.16 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 14.7 M | 15.1 M | 14.7 M | 14.7 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 44.5 M | 6.35 M | 16.1 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.36 B | $ 180.67 | 4.35 % | $ 13.5 B |  USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 11.25 | 3.21 % | $ 1.69 B | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
92.8 M | $ 33.47 | 4.72 % | $ 1.54 B | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.32 | 1.23 % | $ 1.66 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.33 | 0.76 % | $ 125 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 288.17 | 3.19 % | $ 8.13 B | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.59 | -4.08 % | $ 36.7 M | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 39.05 | 3.88 % | $ 5.82 K | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 63.18 | 2.3 % | $ 93.5 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 24.95 | 3.44 % | $ 211 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
730 M | $ 92.98 | 2.83 % | $ 12.6 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.03 | 7.41 % | $ 1.23 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 4.28 | 4.39 % | $ 906 M | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
106 M | $ 6.45 | 1.9 % | $ 172 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | 3.01 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.95 | 6.14 % | $ 398 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.45 | 4.08 % | $ 374 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.73 | 6.34 % | $ 30.6 M | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 54.92 | 1.67 % | $ 1.61 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 38.46 | 4.68 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 64.58 | 2.87 % | $ 3.52 B |  Britain |
 |
LENSAR
LNSR
|
83.7 M | $ 5.92 | 3.86 % | $ 70.8 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 87.73 | 3.08 % | $ 3.05 B | USA |
 |
FONAR Corporation
FONR
|
53.1 M | $ 18.71 | 0.16 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |